Computational Studies Devoted to the Catalytic Mechanism of Threonine Aldolase, a Critical Enzyme in the Pharmaceutical Industry to Synthesize beta-Hydroxy-alpha-amino Acids

• Type: Article in International Scientific Journal
• Date: 2022

Authors

Rocha, JF (Author) Other; Sergio Filipe Sousa (Author) FCUP; Cerqueira, NMFSA (Author) Other

Journal

Title: Acs Catalysis

Vol. 12

Pages: 4990-4999

ISSN: 2155-5435

Publisher: American Chemical Society

Indexing

ISI Web of Knowledge - 0 Citations

Other information

Authenticus ID: P-00W-X9B

DOI: 10.1021/acscatal.1c05567

Abstract (EN): The catalytic mechanism of threonine aldolase (TA) was herein studied in atomic detail employing the computational ONIOM hybrid QM/MM methodology. TA is a PLP-dependent enzyme that catalyzes the retro-aldol cleavage of threonine into glycine and acetaldehyde, as well as the reverse reaction. This enzyme is currently seen as the optimal approach for the regioselective synthesis of beta-hydroxy-alpha-amino acids (HAAs), which are very difficult to obtain by standard methods. The results obtained herein show that the catalytic mechanism of TA occurs in three steps: (i) deprotonation of the hydroxyl group of EA1, (ii) covalent bond cleavage, and (iii) hydrolysis. According to the Gibbs free energy profile, the rate-limiting step of the catalytic process is the covalent bond cleavage, which results in the formation of acetaldehyde. The calculated energy barrier for this step is 16.7 kcal mol(-1), which agrees very well with the kinetic data available in the literature (17.4 kcal mol(-1)). All these results can now be used for the optimization of the synthesis of HAAs that serve as building blocks of several commercial drugs, such as antibiotics, immunosuppressants, and the anti-Parkinson's disease drug L-threo-3,4-dihydroxyphenylserine.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 10